Re: COVID-19 "competition" to keep an eye on.

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: COVID-19 "competition" to keep an eye on.

in response to

COVID-19 "competition" to keep an eye on.

10-41

posted on Feb 08, 2021 06:23AM

And this one from Canada: Interferon-lambda

https://www.eurekalert.org/pub_releases/2021-02/uhn-pss020421.php

"TORONTO (February 5, 2021) - A clinical study led by Dr. Jordan Feld, a liver specialist at Toronto Centre for Liver Disease, University Health Network (UHN), showed an experimental antiviral drug can significantly speed up recovery for COVID-19 outpatients - patients who do not need to be hospitalized."

Resverlogix needs to speed things up with apabetalone, a potential therapeutic for COVID 19 infection.